Skip to main content
Log in

Toll-like Receptor Expression on Peripheral Blood Mononuclear Cells in Asthmatics; Implications for Asthma Management

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Background

Accumulating evidence indicates that cells expressing Toll-like receptors (TLRs) play an important role in allergic diseases. The authors undertook this study to explore the hypothesis that TLR-mediated inflammatory signals are important from the perspective of asthma management.

Methods

The expressions of TLR1, TLR2, TLR3, TLR4, TLR6, and TLR9 and levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8, and IFN-γ) on the peripheral blood mononuclear cells (PBMCs) of 36 stable asthmatics on treatment (the on-treatment group), 15 asthmatics (the treatment-naïve group) before and after a 7-day course of oral prednisolone (30 mg/day), and on the PBMCs of 15 healthy controls were measured after in vitro stimulation using TLR-specific ligands.

Results

In the on-treatment group, TLR1, TLR2, TLR6, and TLR9 expressions on PBMCs were significantly different between asthmatics and controls. And the expression of TLR4 on PBMCs and TNF-α production stimulated by lipopolysaccharide (LPS), were significantly higher in mild to moderate than in severe asthmatics. Interestingly, in the treatment-naïve group, short-term prednisolone significantly increased LPS-induced TNF-α and IFN-γ productions by PBMCs.

Conclusion

TLR-mediated inflammatory signals contribute to the development and severity of asthma and are not reduced by glucocorticoid treatment, which suggests that a TLR-specific antagonist and glucocorticoid are required for the effective control of airway inflammation in asthmatics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

LPS:

Lipopolysaccharide

PAMPs:

Pathogen-associated molecular patterns

PBMCs:

Peripheral blood mononuclear cells

PGN:

Peptidoglycan

TLRs:

Toll-like receptors

References

  1. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1:135–45.

    Article  CAS  PubMed  Google Scholar 

  2. Koch A, Knobloch J, Dammhayn C, et al. Effect of bacterial endotoxin LPS on expression of INF-gamma and IL-5 in T-lymphocytes from asthmatics. Clin Immunol. 2007;125:194–204.

    Article  CAS  PubMed  Google Scholar 

  3. Sukkar MB, Xie S, Khorasani NM, et al. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol. 2006;118:641–8.

    Article  CAS  PubMed  Google Scholar 

  4. Lun SW, Wong CK, Ko FW, et al. Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol. 2009;29:330–42.

    Article  CAS  PubMed  Google Scholar 

  5. Woodruff PG, Khashayar R, Lazarus SC, et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol. 2001;108:753–8.

    Article  CAS  PubMed  Google Scholar 

  6. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. 2009;6:256–9.

    Article  CAS  PubMed  Google Scholar 

  7. Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res. 2003;9:293–300.

    CAS  PubMed  Google Scholar 

  8. National Institutes of Health. National Heart, Lung, and Blood Institute. 2007. National asthma education and prevention program expert panel report II: guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services, Bethesda, MD. NIH Publication No. 08-4051

  9. Boulet LP, Becker A, Bérubé D, et al. Canadian asthma consensus report. Can Med Assoc J. 1999;161(Suppl11):S1–62.

    CAS  Google Scholar 

  10. Ungar WJ, Champman KR, Santos MT. Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med. 2002;165:190–4.

    PubMed  Google Scholar 

  11. Camateros P, Moisan J, Hénault J, et al. Toll-like receptors, cytokines and the immunotherapeutics of asthma. Curr Pharm Des. 2006;12:2365–74.

    Article  CAS  PubMed  Google Scholar 

  12. Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol. 2008;121:5–10.

    Article  CAS  PubMed  Google Scholar 

  13. Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res. 2003;9:293–300.

    CAS  PubMed  Google Scholar 

  14. Zhang N, Truong-Tran QA, Tancowny B, et al. Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J Immunol. 2007;179:578–89.

    CAS  PubMed  Google Scholar 

  15. Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc. 2004;1:222–30.

    Article  CAS  PubMed  Google Scholar 

  16. Morjaria JB, Chauhan AJ, Babu KS, et al. The role of a soluble TNFα receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax. 2008;63:584–91.

    Article  CAS  PubMed  Google Scholar 

  17. Erin EM, Leaker BR, Nicholson GC, et al. The effects of a monoclonal antibody directed against tumor necrosis factor-α in asthma. Am J Respir Crit Care Med. 2006;174:753–62.

    Article  CAS  PubMed  Google Scholar 

  18. Wenzel SE, Barnes PJ, Bleecker ER, et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor α blockade in severe persistent asthma. Am J Respir Crit Care Med. 2009;179:549–58.

    Article  CAS  PubMed  Google Scholar 

  19. Yang M, Kumar RK, Foster PS. Interferon-gamma and pulmonary macrophages contribute to the mechanisms underlying prolonged airway hyperresponsiveness. Clin Exp Allergy. 2009;40:163–73.

    Google Scholar 

  20. Jeon SG, Oh SY, Park HK, et al. TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA. J Allergy Clin Immunol. 2007;120:803–12.

    Article  CAS  PubMed  Google Scholar 

  21. Kumar RK, Webb DC, Herbert C, et al. Interferon-gamma as a possible target in chronic asthma. Inflamm Allergy Drug Targets. 2006;5:253–6.

    Article  CAS  PubMed  Google Scholar 

  22. Sin DD, Sutherland ER. Obesity and the lung: 4. Obesity and asthma. Thorax. 2008;63:1018–23.

    Article  CAS  PubMed  Google Scholar 

  23. Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118:1470–6.

    Article  CAS  PubMed  Google Scholar 

  24. Nahm DH, Lee KH, Shin JY, et al. Identification of alpha-enolase as an autoantigen associated with severe asthma. J Allergy Clin Immunol. 2006;118:376–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant of the Korea Health 21 R&D Project (A030001) from the Ministry of Health and Welfare, Republic of Korea, and by a grant from Seoul National University Hospital (0420061070).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heung-Woo Park.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 61 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chun, E., Lee, SH., Lee, SY. et al. Toll-like Receptor Expression on Peripheral Blood Mononuclear Cells in Asthmatics; Implications for Asthma Management. J Clin Immunol 30, 459–464 (2010). https://doi.org/10.1007/s10875-009-9363-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-009-9363-z

Keywords

Navigation